Amerigo Scientific — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Amerigo Scientific is a specialized distributor and service provider in the life science research tools sector, serving academic, biotech, and pharmaceutical research customers. The company's model is built on aggregating a vast portfolio of third-party and some proprietary products, such as the Valpha® virus removal filters and the Proteonano™ UltraPlex proteomics platform, across areas like diagnostics, antibodies, cell culture, and nucleic acid synthesis. It generates revenue through product sales and value-added services like assay development, calibration, and custom synthesis, positioning itself as a one-stop-shop partner for research laboratories. As a private company, it competes in the fragmented research reagents and consumables market by emphasizing product quality, technical expertise, and global sourcing.

DiagnosticsAntibodies

Technology Platform

Global life science product distribution and integration platform, supplemented by proprietary technologies like Valpha® virus removal filters for bioprocessing and the Proteonano™ UltraPlex automated proteomics platform.

Opportunities

Growth is driven by increasing global life science R&D spending, the expansion of biologics manufacturing (boosting demand for products like virus filters), and the trend towards outsourcing specialized research services.

The company's move into proprietary platforms like proteomics allows it to capture higher value in growing analytical segments.

Risk Factors

Key risks include intense competition from large global distributors, dependence on third-party suppliers and complex supply chains, and the potential for inventory obsolescence due to rapid technological change in research tools.

As a private company, access to growth capital may also be a constraint.

Competitive Landscape

Amerigo Scientific competes in a fragmented but top-heavy market. It faces direct competition from global giants (Thermo Fisher, Merck KGaA, Danaher) and numerous niche distributors and online marketplaces. Its differentiation relies on a curated product portfolio, technical service, proprietary platform offerings, and a focus on specific customer segments within the broad research community.

More companies in Biologics / Biosimilars →More companies in United States →